Mar 20 |
IGC Pharma Announces Positive Interim Results for IGC-AD1 in Reducing Alzheimer’s Agitation
|
Mar 20 |
IGC PHARMA Announces its Participation at the Benzinga Virtual Healthcare Summit 2024
|
Mar 12 |
IGC Pharma (IGC): Healthcare Leader Terry Lierman Joins Board to Advance Alzheimer’s Pipeline
|
Feb 28 |
Promising Results: TGR-63 Enhances Memory in Alzheimer's Mouse Model
|
Feb 23 |
IGC Pharma Announces Equity Analyst Coverage by Ascendiant with a "Buy" Recommendation and $3.00 Price Target
|
Feb 19 |
India Globalization Capital GAAP EPS of -$0.09 misses by $0.05, revenue of $0.2M misses by $0.02M
|
Feb 17 |
IGC Pharma Reports Third Quarter Fiscal 2024 Results
|
Feb 1 |
IGC Pharma Announces TGR-63 Reduces Agitation in Alzheimer's Mouse Model
|
Jan 23 |
Why IGC Pharma Stock Is Moving Higher
|
Jan 23 |
IGC Pharma Breakthrough: Preclinical Trial Data Shows TGR-63 Reduces Plaque in Alzheimer’s
|